Sign in
4

Changes in Ownership

IMMUCELL CORP /DE/ Filed Acc 0001437749-25-034257

Options or other derivatives

  • President and CEO acquired 74,277 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
te Boekhorst Paul Francis Olivier President and CEO 2025-11-07 Grant or award · Stock Options (right to buy) +74,277 $6.10 $453,090 150,260 D
Loading xslF345X05/rdgdoc.xml…